Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Amel Besseghir"'
Autor:
Helle Lynggaard, James Bell, Christian Lösch, Amel Besseghir, Khadija Rantell, Volker Schoder, Vivian Lanius
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-15 (2022)
Abstract Clinical study protocols are the foundation of good clinical studies. Prospective and multidisciplinary collaboration that pays attention to the design of all components of the study protocol can ensure that a clinical study will answer the
Externí odkaz:
https://doaj.org/article/5bcd4a8937fe437cb3502ec61c52e7a2
Autor:
Valérie Boilet, Catherine Fagard, Cécile Rabian, Sybilla Peron, Caroline Roussillon, Françoise Couturier, Isabelle Cohen-Codar, Pierre-Marie Girard, Monique Termote, Eric Bellissant, Olivier Bouchaud, Karine Amat, Babacar Sylla, Aïda Benalycherif, O. Patey, Jean-Marie Poirier, Anne-Marie Taburet, Yazdan Yazdanpanah, Isabelle Poizot, Laetitia Moinot, Elisabeth Rouveix, Patrick Mercié, Eve Todesco, Amel Besseghir, Stéphane De Wit, Isabelle Pellegrin, Bruno Spire, Geneviève Chêne, Adélaïde Perrier, Laurence Morand-Joubert, Sandrine Couffin-Cadiergues, Roland Landman, Jean-Luc Meynard, S. Kolta, Vincent Bouteloup
Publikováno v:
Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2018, 73 (6), pp.1672-1676. ⟨10.1093/jac/dky055⟩
Journal of Antimicrobial Chemotherapy, 2018, 73 (6), pp.1672-1676. ⟨10.1093/jac/dky055⟩
Journal of Antimicrobial Chemotherapy, Oxford University Press (OUP), 2018, 73 (6), pp.1672-1676. ⟨10.1093/jac/dky055⟩
Journal of Antimicrobial Chemotherapy, 2018, 73 (6), pp.1672-1676. ⟨10.1093/jac/dky055⟩
Background: Sparing of antiretroviral drug classes could reduce the toxicity and cost of maintenance treatment for HIV infection. Objectives: To evaluate the non-inferiority of efficacy and the safety of lopinavir/ritonavir (r) monotherapy versus a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aab93fe6ca422ebbe14261f851b46f57
https://doi.org/10.1093/jac/dky055
https://doi.org/10.1093/jac/dky055
Autor:
Sophie, Matheron, Diane, Descamps, Sebastien, Gallien, Amel, Besseghir, Pierre, Sellier, Laurent, Blum, Emmanuel, Mortier, Charlotte, Charpentier, Roland, Tubiana, Florence, Damond, Gilles, Peytavin, Diane, Ponscarme, Fideline, Collin, Francoise, Brun-Vezinet, Genevieve, Chene, L, Marchand
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
First-line raltegravir-containing combination antiretroviral therapy in 30 patients living with HIV-2 was well tolerated and yielded a median CD4 gain at 1 year of 87 cells/µL, and HIV-2 RNA
Background New options for first-line treatment of hu
Background New options for first-line treatment of hu
Autor:
Pierre Versmisse, Bénédicte Charmeteau-de Muylder, Victor Appay, Amel Besseghir, Olivier Lambotte, Glenn Wong, Rémi Cheynier, Mathieu Angin, Françoise Brun-Vézinet, Laura Papagno, Sarah Rowland-Jones, Charles Bayard, Sophie Matheron, Asier Sáez-Cirión, Rodolphe Thiébaut, Delphine Sauce, Faroudy Boufassa, Gianfranco Pancino, Annie David
Publikováno v:
Journal of Immunology
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2016, 197 (7), pp.2787-95. ⟨10.4049/jimmunol.1600693⟩
Journal of Immunology, 2016, 197 (7), pp.2787-95. ⟨10.4049/jimmunol.1600693⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2016, 197 (7), pp.2787-95. 〈10.4049/jimmunol.1600693〉
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2016, 197 (7), pp.2787-95. ⟨10.4049/jimmunol.1600693⟩
Journal of Immunology, 2016, 197 (7), pp.2787-95. ⟨10.4049/jimmunol.1600693⟩
Journal of Immunology, Publisher : Baltimore : Williams & Wilkins, c1950-. Latest Publisher : Bethesda, MD : American Association of Immunologists, 2016, 197 (7), pp.2787-95. 〈10.4049/jimmunol.1600693〉
Compared with HIV-1, HIV-2 infection is characterized by a larger proportion of slow or nonprogressors. A better understanding of HIV-2 pathogenesis should open new therapeutic avenues to establish control of HIV-1 replication in infected patients. I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a560894bf636b8b16e249a4190519de6
https://hal.inria.fr/hal-01406621/file/Angin-Wongetal-20160715-HA-merged.pdf
https://hal.inria.fr/hal-01406621/file/Angin-Wongetal-20160715-HA-merged.pdf
Autor:
François Eugène, Jean-Christophe Gentric, Thomas Ronzière, Jean-Yves Gauvrit, Jean-Christophe Ferré, Hélène Raoult, Amel Besseghir
Publikováno v:
American Journal of Neuroradiology
American Journal of Neuroradiology, American Society of Neuroradiology, 2014, 36, pp.126-132. ⟨10.3174/ajnr.A4071⟩
American Journal of Neuroradiology, 2014, 36, pp.126-132. ⟨10.3174/ajnr.A4071⟩
AJNR Am J Neuroradiol
American Journal of Neuroradiology, American Society of Neuroradiology, 2014, 36, pp.126-132. ⟨10.3174/ajnr.A4071⟩
American Journal of Neuroradiology, 2014, 36, pp.126-132. ⟨10.3174/ajnr.A4071⟩
AJNR Am J Neuroradiol
International audience; BACKGROUND AND PURPOSE: Little is known about the consequences of arterial wall damage that may be due to mechanical endovascular thrombectomy. Our aim was to perform 1-year MR angiographic and clinical follow-up of patients t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6b100c00eaaf18a05f02ed364a52769
https://www.hal.inserm.fr/inserm-01102328
https://www.hal.inserm.fr/inserm-01102328